Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Non-Current Debt (2023 - 2025)

Historic Non-Current Debt for Sanara MedTech (SMTI) over the last 5 years, with Q3 2025 value amounting to $45.1 million.

  • Sanara MedTech's Non-Current Debt rose 4991.59% to $45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.1 million, marking a year-over-year increase of 4991.59%. This contributed to the annual value of $30.7 million for FY2024, which is 23675.93% up from last year.
  • Latest data reveals that Sanara MedTech reported Non-Current Debt of $45.1 million as of Q3 2025, which was up 4991.59% from $44.2 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Non-Current Debt registered a high of $45.1 million during Q3 2025, and its lowest value of $8.8 million during Q1 2024.
  • Moreover, its 3-year median value for Non-Current Debt was $30.1 million (2024), whereas its average is $26.1 million.
  • The largest annual percentage gain for Sanara MedTech's Non-Current Debt in the last 5 years was 39500.76% (2025), contrasted with its biggest fall of 4991.59% (2025).
  • Over the past 3 years, Sanara MedTech's Non-Current Debt (Quarter) stood at $9.1 million in 2023, then skyrocketed by 236.76% to $30.7 million in 2024, then soared by 46.92% to $45.1 million in 2025.
  • Its last three reported values are $45.1 million in Q3 2025, $44.2 million for Q2 2025, and $43.4 million during Q1 2025.